This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Symyx Direct Bridges The Gap Between Bioinformatics And Cheminformatics

SUNNYVALE, Calif., June 22, 2010 (GLOBE NEWSWIRE) -- Symyx Technologies, Inc. (Nasdaq:SMMX) has released the Symyx Direct 7.0 data cartridge — an innovative, one-stop solution for registering, searching, and retrieving chemical and biological entities stored in relational databases. Supporting the continued expansion of biologics in today's pharmaceutical, biotech, and materials science R&D pipelines, Symyx Direct 7.0 improves R&D efficiency, project team collaboration, and IP management by enabling multidisciplinary project teams to visualize, explore, and compare novel macromolecular sequences and chemical structures stored in a single, fully searchable corporate registry system.

"Biologics now represent over 30%, and in some cases over 50%, of our customers' product pipelines," said Dr. Trevor Heritage, president, Symyx Software. "Responding to our industry's critical need for end-to-end combined biologics and chemical acquisition, registration, and management — and guided by our Biologics Advisory Board — Symyx is pleased to introduce an enhanced data cartridge that improves the management and re-use of broader, deeper IP in today's increasingly integrated chemical and biological R&D environment."

Many scientists today are searching for ways to reduce off-target effects and improve the stability of chemically modified short interfering RNA (siRNA) sequences, peptides, and other large molecules. Aiding these efforts, Symyx Direct 7.0 supports natural post- translational modifications (PTM) and custom modifications while also providing seamless support for D-amino acids and complex cyclizations, including the imidazolinone fluorophore found in the fluorescent proteins.

Symyx Direct 7.0 offers a new, hybrid representation that combines the best features of bioinformatics and cheminformatics notations, improving multidisciplinary collaborative research by enabling scientists to:

  • Register and retrieve molecules, reactions, and biomolecular sequences including peptides, oligonucleotides, and oligosaccharides
  • Search for and view chemical modifications in sequences
  • Develop structure-activity correlations in sequences

Used by more than 80 percent of life sciences organizations worldwide, the Symyx Direct data cartridge offers proven performance with databases containing more than 30 million structures and more than 17 million reactions.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs